Sector consensus Regeneron Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-10 pm EDT			5-day change	1st Jan Change
748.87 ^USD	-2.47%		-1.70%	-2.98%

Apr. 08	Bernstein Adjusts Regeneron Pharmaceuticals Price Target to $921 From $925, Maintains Outperform Rating	MT
Apr. 08	Regeneron Expects $0.81 per Share Net Income Impact From $102 Million R&D Charges for Q1	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
REGENERON PHARMACEUTICALS, INC.			875.45	+16.9%	28
UCB			284.65	+3.51%	20
SAMSUNG BIOLOGICS CO.,LTD.			2,247,134.38	+43.04%	25
CSL LIMITED			143.17	+45.14%	16
BIOGEN INC.			207	+19.67%	30
MODERNA, INC.			45.15	-11.4%	20
INNOVENT BIOLOGICS, INC.			101.28	+30.72%	26
INCYTE CORPORATION			107.27	+11.66%	22
SWEDISH ORPHAN BIOVITRUM AB			428.5	+5.49%	10
BRIDGEBIO PHARMA, INC.			100.61	+34.88%	23
ALTEOGEN INC.			435,000	+20.33%	4
BIOMARIN PHARMACEUTICAL INC.			88.87	+62.97%	23
AXSOME THERAPEUTICS, INC.			223.99	+25.76%	21
KRYSTAL BIOTECH, INC.			314	+21.24%	9
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD	-	-	89.17	+8.48%	1
3SBIO INC.			33.08	+65.26%	11
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-	-	50	+27.94%	1
GRIFOLS, S.A.			14.96	+67.48%	12
SHANGHAI HENLIUS BIOTECH, INC.			91.66	+26.1%	8
Average			141,333.33	+27.64%	16
Weighted average by Cap.			274,095.96	+23.87%	21